Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T13:44:47.752Z Has data issue: false hasContentIssue false
  • English
  • Français

Subjective quality of life and drug treatment for schizophrenia

Published online by Cambridge University Press:  02 January 2018

S. Sengupta  and
N. Kar
S. Sengupta
Affiliation:
Department of Psychiatry, Kasturba Medical College, Maniapal, 576 I19, Karnataka, India
N. Kar
Affiliation:
Department of Psychiatry, Kasturba Medical College, Maniapal, 576 I19, Karnataka, India
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 171 , Issue 6 , December 1997 , pp. 587
Copyright
Copyright © 1997 The Royal College of Psychiatrists 

References

Awad, A. G. & Hogan, T. P. (1994) Subjective response to neuroleptics and quality of life: implications for treatment outcome. Acta Psychiatrica Scandinavico, 89 (suppl. 380), 27–32.CrossRefGoogle Scholar
Franz, M., Lis, S., Plüddemann, K., et al (1997) Conventional versus atypical neuroleptics: subjective quality of like in schizophrenic patients. British Journal of Psychiatry, 170, 422–425.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.